Lifecare AS announced positive results from the first week of sensor longevity trials. Reference is made to press release 18 June 2024 when the company initiated the trials with wireless readout. Already after the first week of the longevity trials, conducted at the Norwegian University of Life Sciences (NMBU), the reports show very positive results.

The dog, Elli, is the first patient with the wireless glucose sensor. During the first seven days, the sensor implanted under Elli's skin have transmitted far more than 1,000 data points to an external reader. A week's lifespan under the skin of a dog, in addition to the fact that such a large amount of data is read from the implanted sensor, is obviously a huge step for us in the right direction, says Managing Director Jo Amundstad of the subsidiary Lifecare Veterinary.

He is responsible for the study in collaboration with NMBU. This is really a huge performance. Have been eager to start the longevity studies with wireless data-readout, being essential to confirm long-term sensor functionality in live tissue.

Previously, the Sencell sensor has been implanted in clinical trials for up to three days in humans, with wired readout. It is groundbreaking for technology when note a functionality of more than a week in-vivo.